Skip to main navigation
Skip to search
Skip to main content
Sort by
Neuroscience
Lipopolysaccharide
100%
CXCL10
69%
Chemokine
58%
Anti-Inflammatory
53%
Ovariectomy
42%
Astrocyte
37%
CCL2
37%
Behavior (Neuroscience)
37%
Narcotic Antagonist
37%
Blood Plasma
33%
Interleukin 1
29%
Paraventricular Nucleus
29%
Social Defeat
28%
μ-Opioid Receptor
26%
Interleukin 6
22%
Arcuate Nucleus
20%
Gamma Interferon Inducible Protein 10
20%
Microglia
20%
Leptin
19%
Receptor
19%
Glial Fibrillary Acidic Protein
18%
Sickness Behavior
18%
Mood Disorder
17%
Ghrelin
17%
Interferon
17%
C57BL 6 Mouse
16%
Leptin Receptor
16%
Brain Region
16%
TLR 4
15%
Insulin
15%
Intestine
15%
In Vitro
14%
Nitric Oxide Synthase
14%
Inducible Nitric Oxide Synthase
14%
Synuclein
14%
Neuroreceptor
14%
Positive Allosteric Modulator
14%
Astrocytoma
14%
Nicotinic Acetylcholine Receptor
14%
Chemotherapy
14%
Cytokine Production
14%
Enzymes
13%
Necrosis
12%
Cytokine
12%
Parkinson's Disease
11%
Hormone Receptor
10%
Messenger RNA
10%
Cerebellum
10%
Brainstem
10%
Human Immunodeficiency Virus
9%
Keyphrases
CXCL10
36%
Lipopolysaccharide-induced
28%
Lipopolysaccharide
25%
Chemokine Ligand 2 (CCL2)
24%
Inflammatory Pathways
24%
Neuroinflammation
22%
Human Astrocytes
21%
Astroglial Cells
19%
Interleukin-1β
19%
Chemokine Expression
17%
Protective Effect
17%
Behavioral Deficits
15%
Ovariectomy
14%
Social Defeat
14%
Weight Gain
14%
Paraventricular nucleus
14%
Nicotinic Acetylcholine Receptor (nAChR)
14%
Metabolic Hormones
14%
PAM2
14%
Sickness Behavior
14%
Neuromelanin
14%
A172
14%
Expression Activity
14%
Human Microglia
14%
Lipopolysaccharide-induced Inflammation
14%
Astrocytoma Cells
14%
Nitric Oxide Synthase
14%
Alpha-synuclein (α-syn)
14%
Sex Change
14%
Normal Human Astrocytes
14%
Neuroimmune
14%
Inflammation
13%
Parkinson's Disease
13%
Dorsal Vagal Complex
12%
Naltrexone
11%
Mood Disorders
10%
Astrocytes
10%
Arcuate nucleus
10%
Glial Cells
9%
Nicotine
9%
Inflammatory Chemokines
7%
Anti-inflammatory Effect
7%
Enzyme-linked Immunosorbent Assay (ELISA)
7%
Μ-opioid Receptor Antagonist
7%
Interleukin-6
7%
Sickness
7%
Neuropathic Pain
7%
Whole Brain
7%
United States
7%
Anxiety Disorders
7%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
50%
Lipopolysaccharide
48%
Chemokine
45%
Nervous System Inflammation
33%
Positive Allosteric Modulator
28%
Lipopolysaccharide-Induced Inflammation
28%
Diseases
27%
Antiinflammatory Activity
25%
Cytokine
18%
Mood Disorder
16%
Nicotinic Receptor
16%
Neuropathic Pain
15%
Naltrexone
14%
Antiinflammatory Agent
14%
Anxiety Disorder
14%
Pharmacotherapy
14%
Autism
14%
Chemotherapy Regimen
14%
Interleukin 1
12%
Oxaliplatin
10%
Enzyme-Linked Immunosorbent Assay
9%
C57BL 6 Mouse
8%
Tumor Necrosis Factor
8%
Lipopolysaccharide-Induced Neuroinflammation
8%
Mu Opiate Receptor Antagonist
8%
Interleukin 6
6%
Gamma Interferon Inducible Protein 10
5%
Immunoglobulin Enhancer Binding Protein
5%
Alzheimer's Disease
5%
Monocyte Chemotactic Protein 1
5%
Inflammatory Bowel Disease
5%
Preclinical Study
5%
Neuroprotective Agent
5%
Parkinson's Disease
5%